Discharge Planning in Emergency Department for Frail Older With AHF
1 other identifier
interventional
1,260
1 country
1
Brief Summary
Objectives: To demonstrate the efficacy of care transition holistic intervention (Multilevel Guided Discharge Planning, MGDP) in reducing 30-day adverse outcomes among frail older patients with acute heart failure (AHF) discharged from Emergency Departments (EDs) and to validate the results of MGDP in real life. Method: Investigators will select frail patients ≥70 years with primary diagnosis of AHF discharged from EDs. The intervention will consist of MGDP implementation: 1) checklist that includes clinical recommendations and resources activations; 2) scheduling of early visit with the specialist; 3) communication with primary care; 4) providing a written instruction sheet to patient or caregiver. Phase 1: matched-pair cluster randomized clinical trial. EDs were randomly allocated to intervention (n = 10) or control (n = 10) group. Investigators will compare the outcomes between intervention and control groups. Phase 2: a quasi-experimental study. The 20 EDs will carry out the intervention. Investigators will compare the outcomes between phase 1 and phase 2 of intervention group and between phase 1 and phase 2 of control group. The main outcome is a 30-day composite endpoint (ED revisit or hospital admission for AHF and cardiovascular death) after being discharged.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 28, 2018
CompletedFirst Posted
Study publicly available on registry
October 5, 2018
CompletedStudy Start
First participant enrolled
May 20, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 15, 2022
CompletedJuly 8, 2019
July 1, 2019
2.6 years
September 28, 2018
July 3, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
30-day emergency revisit or hospital admission for acute heart failure or cardiovascular mortality rate after discharge
The proportion of patients who have emergency revisit or hospital admission for acute heart failure or cardiovascular mortality within 30 days after discharge
at 30 days post-discharge
Secondary Outcomes (13)
All-cause emergency revisit rate
at 30 days post-discharge
Acute heart failure emergency revisit rate
at 30 days post-discharge
Cardiovascular emergency revisit rate
at 30 days post-discharge
All-cause hospitalisation rate
at 30 days post-discharge
Acute heart failure hospitalisation rate
at 30 days post-discharge
- +8 more secondary outcomes
Study Arms (2)
Multilevel Guided Discharge Planning
EXPERIMENTALStandard of care
ACTIVE COMPARATORInterventions
Clinical recommendations and resources activations + scheduling of early visit with the specialist + communication with primary care + written instruction sheet to the patient
Eligibility Criteria
You may qualify if:
- Age ≥70 years.
- Diagnosis of descompensated chronic heart failure.
- Screening for frailty positive (ISAR ≥ 2).
- Planned discharge home from Emergency Department (included observation and short stay unit).
- Written informed consent provided by the patient or proxy.
You may not qualify if:
- De novo (new onset) acute heart failure (AHF).
- Severe episode of acute heart failure (≥9th decile of MEESSI-AHF Score).
- Uncorrected clinically significant primary valvular disease.
- Acute coronary syndrome currently or within 30 days prior to enrolment.
- Surgery or implanted device within 30 days prior to enrolment.
- Significant arrhythmias.
- Uncorrected systolic blood pressure \< 100 mmHg, O2 saturation baseline \< 92%, heart rate \< 60 or \>110 bpm, serum sodium \< 130 mmol/l, serum potassium \>5,5 mmol/l or hemoglobin \<9 g/dL prior to enrolment.
- Planned treatment with vasoactive therapies, ventricular assist device, heart surgery or transplant within 6 months.
- End stage renal disease.
- Severe disability.
- Difficulty intervention due to significant dementia, active delirium or psychiatric disorder.
- Condition with a life expectancy \<1 year.
- Length of stay in Emergency Department ≥96 hours.
- Discharged to facility care.
- Inability of outpatient follow-up.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Clinico San Carlos
Madrid, 28040, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 28, 2018
First Posted
October 5, 2018
Study Start
May 20, 2019
Primary Completion
December 20, 2021
Study Completion
May 15, 2022
Last Updated
July 8, 2019
Record last verified: 2019-07